Physician profile
Markian Stecyk
NPI 1679575617
$1,247.98
in general payments reported to CMS, 2019-2025
18 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.92 · 2020: $43.45 · 2021: $300 · 2022: $122 · 2023: $304 · 2024: $147 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.05 |
| Education | $196.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $347.77 | 2021-2025 | Gamma, Triathlon, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $196.64 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $153.82 | 2024-2025 | |
| Orthofix Medical, INC. | $89.83 | 2022-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $80.13 | 2019-2022 | |
| Terumo Bct, INC. | $53.52 | 2021 | |
| Fidia Pharma USA INC. | $48.51 | 2019-2025 | Hymovis, Triluron |
| Biomarin Pharmaceutical INC. | $46.50 | 2022-2023 | Voxzogo 1.2mg |
| Pacira Pharmaceuticals Incorporated | $34.64 | 2021-2023 | Zilretta, Iovera |
| Kowa Pharmaceuticals America, INC. | $31.41 | 2022 | |
| Bioventus LLC | $30.58 | 2019-2020 | |
| Baxter Healthcare | $24.66 | 2023 | |
| Peter Brasseler Holdings, LLC | $24.50 | 2024 | |
| Polynovo North America LLC | $21.08 | 2025 | Novosorb Btm |
| Vericel Corporation | $20.16 | 2023 | Maci |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $19.25 | 2023 | Celleraterx |
| Ferring Pharmaceuticals INC. | $17.62 | 2022 | |
| Heraeus Medical, LLC. | $7.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markian Stecyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.